FINWIRES · TerminalLIVE
FINWIRES

Atlas Arteria Says Takeovers Panel Declines Interim Order to Block IFM Bidder's Statement

By

-- Atlas Arteria (ASX:ALX) said the Australian Takeovers Panel has declined its request for an interim order to restrain Diamond Infraco 1, a unit of IFM Global Infrastructure Fund, from dispatching its bidder's statement in its current form, pending the final determination of the panel proceedings, according to a Monday Australian bourse filing.

The filing said the panel is still considering whether to conduct proceedings.

Atlas Arteria's board recommended on May 6 that shareholders reject the unsolicited takeover offer from IFM, saying it materially undervalues the company, while also filing an application with the Takeovers Panel seeking to block IFM Global Infrastructure Fund from dispatching a bidder's statement related to its offer.

Related Articles

Asia

CStone Pharmaceuticals Begins Commercial Distribution of Locally Manufactured Pralsetinib

CStone Pharmaceuticals (HKG:2616) began nationwide commercial supply of locally manufactured pralsetinib capsules in China, according to a Monday filing with the Hong Kong bourse.The oncology drugmaker said the first batch shipment marks the establishment of a localized supply chain for the therapy.CStone expects full-year 2026 sales revenue for pralsetinib capsules to exceed 300 million yuan, the filing said.

$HKG:2616
Asia

Update: Metcash Expects Year-Over-Year Increase in Fiscal Year 2026 Revenue; Shares Up 8%

(Updates to add stock movement in the headline and last paragraph)Metcash (ASX:MTS) expects fiscal year 2026 revenue of AU$19.6 billion, up 0.7% from the previous year, according to a Monday filing with the Australian bourse.The company also expects fiscal year underlying profit after tax in the range of AU$268 million to AU$270 million.Metcash said ongoing cost initiatives are expected to yield at least around AU$25 million of annualized savings in fiscal year 2027.Additionally, the company has increased inventory levels as a precaution, even though it has not yet experienced any supply shortages due to the Middle East conflict.The company's shares rose around 8% in recent Monday trade.

$ASX:MTS
Asia

Aldoro Resources Reports 15% Tonnage Increase in Namibia Rare Earth Project Resource; Shares Up 5%

Aldoro Resources (ASX:ARN) said its updated inferred mineral resource estimate (MRE) for its 85%-owned Kameelburg project in Namibia stands at 597.1 million tonnes at 2.5% total rare earth oxide (TREO) equivalent, a 15% tonnage increase on the September 2025 Phase I MRE at unchanged grade, according to a Monday Australian bourse filing.The company said the high-grade subset has expanded to 312.7 million tonnes at 2.9% TREO equivalent at a 1% TREO cut-off, with high-grade tonnes more than doubling since the September 2025 update, supporting selective bulk open-pit mining in the early years of development.A maiden strontium mineral resource has been declared as a co-located by-product credit of 596 million tonnes at 2.2% strontium, inclusive of and not additional to the TREO resource, the filing added.The MRE is based on 29 diamond drill holes for 12,044 meters, with the final Kameelburg Phase II MRE expected in June, with the resource remaining open along strike, down-dip, and at depth in all directions, the filing added.The company's shares rose 5% in recent Monday trade.

$ASX:ARN